BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35701121)

  • 21. Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients.
    O'Brien MJ; Lee JY; Carnethon MR; Ackermann RT; Vargas MC; Hamilton A; Mohanty N; Rittner SS; Park JN; Hassan A; Buchanan DR; Liu L; Feinglass J
    PLoS Med; 2016 Jul; 13(7):e1002074. PubMed ID: 27403739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Crotty K; Yun JDY; Middleton JC; Feltner C; Taylor-Phillips S; Barclay C; Dotson A; Baker C; Balio CP; Voisin CE; Harris RP
    JAMA; 2021 Aug; 326(8):744-760. PubMed ID: 34427595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.
    Hoerger TJ; Hicks KA; Sorensen SW; Herman WH; Ratner RE; Ackermann RT; Zhang P; Engelgau MM
    Diabetes Care; 2007 Nov; 30(11):2874-9. PubMed ID: 17698614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An economic evaluation for prevention of diabetes mellitus in a developing country: a modelling study.
    Liu X; Li C; Gong H; Cui Z; Fan L; Yu W; Zhang C; Ma J
    BMC Public Health; 2013 Aug; 13():729. PubMed ID: 23919839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effectiveness of physical leisure time activities on glycaemic control in adult patients with diabetes type 2: A Systematic Review.
    Pai LW; Chang PY; Chen W; Hwu YJ; Lai CH
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-20. PubMed ID: 27820154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-Effectiveness of Primary Prevention with Statin Treatment for Chinese Patients with Type 2 Diabetes.
    Li T; Wan X; Ma J; Wu B
    Adv Ther; 2018 Dec; 35(12):2214-2223. PubMed ID: 30390239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.
    Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yield of opportunistic targeted screening for type 2 diabetes in primary care: the diabscreen study.
    Klein Woolthuis EP; de Grauw WJ; van Gerwen WH; van den Hoogen HJ; van de Lisdonk EH; Metsemakers JF; van Weel C
    Ann Fam Med; 2009; 7(5):422-30. PubMed ID: 19752470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?
    Siegel KR; Ali MK; Zhou X; Ng BP; Jawanda S; Proia K; Zhang X; Gregg EW; Albright AL; Zhang P
    Diabetes Care; 2020 Jul; 43(7):1557-1592. PubMed ID: 33534729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation.
    Su S; Wong WC; Zou Z; Cheng DD; Ong JJ; Chan P; Ji F; Yuen MF; Zhuang G; Seto WK; Zhang L
    Lancet Glob Health; 2022 Feb; 10(2):e278-e287. PubMed ID: 35063115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Testing for Diabetes Among US Adults With Overweight or Obesity, 2016-2019.
    Chen Y; Lundeen EA; Koyama AK; Kompaniyets L; Andes LJ; Benoit SR; Imperatore G; Rolka DB
    Prev Chronic Dis; 2023 Dec; 20():E116. PubMed ID: 38154119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement.
    Siu AL;
    Ann Intern Med; 2015 Dec; 163(11):861-8. PubMed ID: 26501513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign.
    Omboni S; Carabelli G; Ghirardi E; Carugo S
    Vasc Health Risk Manag; 2013; 9():177-85. PubMed ID: 23662063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic evaluation of orlistat in overweight and obese patients with type 2 diabetes mellitus.
    Maetzel A; Ruof J; Covington M; Wolf A
    Pharmacoeconomics; 2003; 21(7):501-12. PubMed ID: 12696990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of the 2015 US Preventive Services Task Force Screening Criteria for Prediabetes and Undiagnosed Diabetes.
    O'Brien MJ; Bullard KM; Zhang Y; Gregg EW; Carnethon MR; Kandula NR; Ackermann RT
    J Gen Intern Med; 2018 Jul; 33(7):1100-1108. PubMed ID: 29651678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of milk powder fortified with potassium to decrease blood pressure and prevent cardiovascular events among the adult population in China: a Markov model.
    Dainelli L; Xu T; Li M; Zimmermann D; Fang H; Wu Y; Detzel P
    BMJ Open; 2017 Sep; 7(9):e017136. PubMed ID: 28951410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease.
    Chen F; Su W; Becker SH; Payne M; Castro Sweet CM; Peters AL; Dall TM
    PLoS One; 2016; 11(10):e0163627. PubMed ID: 27706216
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.